Scarica l'app Stockscreener
6.42
0.16%
0.010
Dopo l'orario di chiusura:
6.42
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.41
Aprire:
$6.3
Volume 24 ore:
267.08K
Relative Volume:
1.70
Capitalizzazione di mercato:
$221.33M
Reddito:
$44.64M
Utile/perdita netta:
$-10.10M
Rapporto P/E:
-18.66
EPS:
-0.344
Flusso di cassa netto:
$-14.45M
1 W Prestazione:
-1.38%
1M Prestazione:
-21.90%
6M Prestazione:
-33.61%
1 anno Prestazione:
+8.08%
Intervallo 1D:
$6.25
$6.55
Intervallo di 1 settimana:
$5.65
$6.55
Portata 52W:
$4.68
$9.92
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Nome
Fennec Pharmaceuticals Inc
Settore
Industria
Telefono
(919) 636-4530
Indirizzo
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
6.42 | 221.33M | 44.64M | -10.10M | -14.45M | -0.344 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-12 | Iniziato | B. Riley Securities | Buy |
| 2026-01-09 | Iniziato | Piper Sandler | Overweight |
| 2022-11-22 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | Iniziato | CapitalOne | Overweight |
| 2022-08-08 | Ripresa | Craig Hallum | Buy |
| 2020-06-05 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-10-11 | Iniziato | Goldman | Buy |
Mostra tutto
Fennec Pharmaceuticals Inc Borsa (FENC) Ultime notizie
Trend Recap: Can Fennec Pharmaceuticals Inc sustain earnings growth2026 Short Interest & Step-by-Step Swing Trade Plans - baoquankhu1.vn
(FENC) Risk Channels and Responsive Allocation - Stock Traders Daily
FENC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Adherex Technologies (NASDAQ:FENC) Cut to Hold at Wall Street Zen - MarketBeat
Adherex Technologies (NASDAQ:FENC) Director Rosty Raykov Sells 10,946 Shares - MarketBeat
[Form 4] FENNEC PHARMACEUTICALS INC. Insider Trading Activity - Stock Titan
Fennec (FENC) CEO gets 200,000 options and new common shares - Stock Titan
FENNEC (FENC) director exercises 15,598 options and sells shares under 10b5-1 plan - Stock Titan
CMO at Fennec (NASDAQ: FENC) receives 120,000 stock options award - Stock Titan
Fennec (NASDAQ: FENC) CCO gets 120,000 options, 20,679 shares - Stock Titan
Public market insider net buying at Fennec Pharmaceuticals (FRX) - The Globe and Mail
FENC (NASDAQ) insider sale notice: 10,946 shares via option exercise - Stock Titan
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
HC Wainwright Has Bearish Forecast for FENC Q1 Earnings - MarketBeat
Equities Analysts Offer Predictions for TSE:FRX Q1 Earnings - MarketBeat
Adherex Technologies Inc. (NASDAQ:FENC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
FENC Stock Price, Quote & Chart | FENNEC PHARMACEUTICALS INC (NASDAQ:FENC) - ChartMill
Aug Ideas: Does Fennec Pharmaceuticals Inc have a competitive edge2026 Trade Ideas & Long-Term Growth Plans - baoquankhu1.vn
CEO Moves: Can Fennec Pharmaceuticals Inc expand its profit marginsWeekly Trade Analysis & Risk Controlled Daily Plans - baoquankhu1.vn
HC Wainwright Issues Negative Forecast for FENC Earnings - MarketBeat
24 new Fennec hires get options at $5.77 under Nasdaq rule - Stock Titan
Can Fennec Pharmaceuticals Inc stock double in the next yearStock Surge & Accurate Intraday Trade Tips - baoquankhu1.vn
Income Plays: Does Fennec Pharmaceuticals Inc have a sustainable dividend2026 Fed Impact & High Return Stock Watch Alerts - baoquankhu1.vn
Fennec Pharmaceuticals 2025 Annual Report: PEDMARK® Commercialization, Risks, and Intellectual Property Overview - minichart.com.sg
Adherex Technologies (NASDAQ:FENC) Cut to Strong Sell at Zacks Research - Defense World
Fennec Posts Record PEDMARK Sales in 2025 as Clinical and Commercial Momentum Builds - TipRanks
Fennec Pharmaceuticals 2025 10-K: Revenue $44.6M, Net Loss $(9.7)M - TradingView
Fennec (NASDAQ: FENC) expands PEDMARK reach and delays generic entry - stocktitan.net
Fennec Pharmaceuticals earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call - MSN
Adherex Technologies (NASDAQ:FENC) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat
FRX.CA Forecast, Price Target & Analyst Ratings | FENNEC PHARMACEUTICALS INC (TSX:FRX) - ChartMill
Fennec (NASDAQ: FENC) CFO exercises 13,072 stock options in Form 4 - Stock Titan
Fennec (NASDAQ: FENC) Chief Strategy Officer exercises options, holds 145,300 shares - Stock Titan
Fennec Pharmaceuticals (FENC) Quarterly Loss Near Breakeven Challenges Bearish Profitability Narratives - Sahm
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2025 Earnings Call Transcript - Insider Monkey
Companies Like Fennec Pharmaceuticals (NASDAQ:FENC) Can Afford To Invest In Growth - Yahoo Finance
Fennec Pharmaceuticals Hits Day Low of CAD 8.26 Amid Price Pressure - Markets Mojo
Fennec Pharmaceuticals Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Day Trade: Will Fennec Pharmaceuticals Inc benefit from AI trendsEarnings Summary Report & Short-Term High Return Ideas - baoquankhu1.vn
Adherex Technologies (FENC) to Release Earnings on Wednesday - MarketBeat
Fennec Pharmaceuticals Reports Record 2025 PEDMARK® Sales Growth and Financial Results, Highlights Pipeline and Global Expansion - minichart.com.sg
(FENC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Fennec Pharmaceuticals Reports Record FY2025 Net Product Sales of $44.6M, Q4 Sales $13.8M - TradingView
Record PEDMARK growth but wider 2025 loss for Fennec (NASDAQ: FENC) - stocktitan.net
Fennec Pharmaceuticals Inc (FENC) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ... By GuruFocus - Investing.com Canada
Fennec Pharmaceuticals misses Q4 estimates on earnings and revenue - MSN
Fennec Pharmaceuticals Inc. (FENC) Misses Q4 EPS Estimates - AlphaStreet
Adherex Technologies Q4 2025 Earnings Call Transcript - MarketBeat
Earnings Call Summary | Fennec Pharmaceuticals(FENC.US) Q4 2025 Earnings Conference - Moomoo
Adherex Technologies Q4 Earnings Call Highlights - MarketBeat
Fennec Pharmaceuticals Inc Azioni (FENC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):